RAIA DROGASIL S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.62 BRL | +2.69% |
|
+0.67% | -12.86% |
| Mar. 06 | Transcript : Raia Drogasil S.A., Q4 2023 Earnings Call, Mar 06, 2024 | |
| Mar. 05 | Raia Drogasil S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
ETFs positioned on Raia Drogasil S.A.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.01% | 21 M€ | -11.76% | - | |
| 1.35% | 12 M€ | +15.09% | - | |
| 1.21% | 15 M€ | -3.58% | ||
| 1.19% | 32 M€ | -7.10% | ||
| 0.28% | 11 M€ | +1.79% | ||
| 0.11% | 441 M€ | +4.60% | - | |
| 0.11% | 2,808 M€ | +5.90% | - | |
| 0.11% | 149 M€ | +2.17% | - | |
| 0.09% | 4 M€ | -4.41% | - | |
| 0.05% | 117 M€ | +1.11% | - | |
| 0.03% | 7 M€ | +1.95% | - | |
| 0.01% | 34 M€ | +2.14% | - | |
| 0.01% | 389 M€ | +6.83% | - | |
| 0.00% | 34 M€ | +6.71% | - | |
| 0.00% | 147 M€ | +4.88% | - | |
| 0.00% | 39 M€ | +3.67% | - | |
| 0.00% | 302 M€ | +3.80% | - | |
| 0.00% | 26 M€ | -4.26% | - | |
| 0.00% | 152 M€ | -3.56% | - | |
| 0.00% | 7 M€ | +0.11% | - | |
| 0.00% | 108 M€ | +2.03% | - | |
| 0.00% | 1 M€ | -.--% | - | |
| 0.00% | 29 M€ | -3.48% | - | |
| 0.00% | 17 M€ | +1.44% | - | |
| 0.00% | 15 M€ | +11.24% | ||
| 0.00% | 52 M€ | -0.60% | - | |
| 0.00% | 8 M€ | -0.60% | - |
Raia Drogasil S.A. specializes in the distribution of medicines, cosmetics and dermocosmetics, perfumery, personal care and beauty products. Net sales break down by family of products as follows:
- branded pharmaceuticals (42%);
- pharmaceutical additives (25.1%) ;
- OTC products (21.3%);
- generic pharmaceutical products (11.4%).
At the end of 2020, its products were marketed through a network of 2,299 pharmacies under the Drogasil (1,304) and Raia (995) brands in Brazil.
Sector
Drug Retailers
Calendar
2024-05-06
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
25.62
BRL
Average target price
30.93
BRL
Spread / Average Target
+20.73%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -12.86% | 8.57B | |
| +32.95% | 1.32B | |
| +6.76% | 419M | |
| +5.93% | 282M | |
| +10.56% | 224M | |
| -8.26% | 85.07M | |
| +20.94% | 59.57M |
- Stock Market
- Equities
- RADL3 Stock
- Funds and ETFs Raia Drogasil S.A.
